Current knowledge of antisense long non-coding RNA in the occurrence and prognosis of skull base tumors

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• Antisense long non-coding RNAs (AS-lncRNAs) are a newly identified class of RNA molecules.
• AS-lncRNAs are increasingly recognized for their significant roles in biological processes, especially in cancer initiation and progression.

Purpose of the Study:

• To investigate the role and potential of AS-lncRNAs in skull base tumors.
• To explore AS-lncRNAs as potential biomarkers for early diagnosis, efficacy assessment, and prognosis prediction in skull base tumors.

Main Methods:

• Analysis of AS-lncRNA expression patterns in skull base tumors.
• Functional studies examining AS-lncRNA regulatory mechanisms, including miRNA sponging and RBP interactions.
• Correlation analysis between AS-lncRNA expression and clinical characteristics of skull base tumors.

Main Results:

• Skull base tumors exhibit distinct AS-lncRNA expression profiles that significantly correlate with clinical features.
• AS-lncRNAs regulate critical tumor processes such as cell cycle, apoptosis, angiogenesis, invasion, and metastasis.
• AS-lncRNAs function as miRNA sponges and interact with RNA-binding proteins (RBPs) to modulate gene expression.

Conclusions:

• AS-lncRNAs are implicated in the pathogenesis and progression of skull base tumors.
• AS-lncRNAs represent promising molecular markers for early detection and prognosis of skull base tumors.
• Further research into AS-lncRNA mechanisms offers insights into tumor etiology and potential therapeutic strategies, including gene therapy.